Analyst Ratings for AzurRx Biopharma (AZRX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2021 | Dawson James | Jason Kolbert | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.85 (3.45) |
305.88% | Details |
| 1/24/2020 | Roth/MKM » Updated 4/1/2021 |
Jonathan Aschoff | New Coverage | Buy (N/A) |
5.00 (7.00) |
1.08 (3.45) |
219.44% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


